Free online education for Ophthalmic Nurses
Macular Disease Foundation Australia (MDFA) has launched free online courses for ophthalmic nurses that have been developed with Australia’s leading retinal specialists, including world-renowned ophthalmologist Professor Paul Mitchell AO.
More than 1.5 million Australians have some evidence of AMD – the leading cause of irreversible severe vision loss and blindness in Australia.
Healthcare professionals are at the frontline of patient interactions and have a valuable role in decreasing preventable blindness and in being an important part of the solution to reduce both the incidence and impact of macular disease.
Online Education Courses
-
Age-related macular degeneration
Macular Disease Foundation Australia is providing this free education module for ophthalmic nurses with the support of the Commonwealth Government.
The course is aimed to increase awareness and knowledge of macular disease to enable early diagnosis and interventions.
The Age-related macular degeneration course comprises 2x 30-minute modules and 2x 15-minute quizzes, and aims to assist you to manage and reduce modifiable risk, and improve your communication with patients about macular disease and it’s impacts.
You will learn about linking patients diagnosed with macular disease with appropriate supports and services, and current best practice and strategies to recognise and encourage high risk individuals to have regular eye examinations.
-
Geographic Atrophy
Navigating the Changing Geographic Atrophy Landscape: A Guide for Clinicians
Recent advancements in clinical trials have shown potential new treatment options for people with geographic atrophy. Due to the pending arrival of these treatments in Australia, it is advised that clinicians provide appropriate counselling and/or non-urgent referral to ophthalmology for baseline testing of geographic atrophy in patients interested in new treatments. Macular Disease Foundation Australia has developed this Government funded guide covering an overview of geographic atrophy, including classification, risk factors, imaging, features associated with progression and an update on treatments.